Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
American Journal of Hematology|June 1, 1985
Treatment of patients with acute nonlymphocytic leukemia in relapse: a Leukemia Intergroup studyJ Goldberg, H Grunwald, W R Vogler, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Cross-resistance pattern of cell lines selected for resistance towards different cytotoxic drugs to membrane-toxic phospholipids in vitroA W Himmelmann, S Danhauser-Riedl, G Steinhauser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group StudyW R Vogler, E Velez-Garcia, R S Weiner, et al.
The American Journal of Medicine|August 26, 1996
Improving the efficacy of preoperative autologous blood donation in patients with low hematocrit: a randomized, double-blind, controlled trial of recombinant human erythropoietinT H Price, L T Goodnough, W R Vogler, et al.
Transfusion|January 1, 1996
The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double-blind, controlled trialT H Price, L T Goodnough, W R Vogler, et al.
Advances in Experimental Medicine and Biology|January 1, 1996
A phase II trial of autologous bone marrow transplantation (ABMT) in acute leukemia with edelfosine purged bone marrowW R Vogler, W E Berdel, R B Geller, et al.
Cancer Treatment Reports|April 1, 1986
Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a Leukemia Intergroup StudyW R Vogler, H D Preisler, E F Winton, et al.
Cancer Letters|December 1, 1987
Lack of therapeutic activity of the lipoidal amine CP-46,665 in rodent tumors and human non-seminomatous germ cell tumors growing in nude miceW E Berdel, M R Berger, H Falk, et al.
Lipids|December 1, 1991
Comparison of selective cytotoxicity of alkyl lysophospholipidsW R Vogler, A C Olson, S Okamoto, et al.
Transfusion|January 1, 1994
A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacyL T Goodnough, T H Price, K D Friedman, et al.
Pageof 13